Please sign in to follow a disease.
New shaver device may speed up uterine polyp surgery
NCT ID NCT02472197
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tested a new device called a hysteroscopic morcellator against the standard resectoscope for removing uterine polyps. The goal was to see which method is faster and safer. The trial involved 90 adults with a single polyp. The morcellator uses suction and mechanical cutting, while the standard tool uses electrical current. Researchers measured surgery time, complications, and how complete the removal was.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Hysteroscopic morcellation procedure
- What this could lead to
- If successful, this could make polyp removal faster and safer, with fewer risks like uterine perforation.
- What could go wrong
- This is a small, completed study (90 participants) comparing two surgical tools, not a new treatment. Results may not apply to all patients or settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
90 people
The number who actually took part.
- Started
-
Sep 2015
- Finished
-
Jul 2018
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All major patients with single endometrial polyp, * Confirmed by a diagnostic hysteroscopy * Greater than or equal to one centimeter in size with no upper size limit * Patient giving informed consent * Subject belonging to a social security organisme Exclusion Criteria: * Ongoing pregnancy or breastfeeding * Progressive malignant gynecological pathology * Evolutionary Genital infection * Suspected malignancy before surgery * Multiple Polyps * Polypoid hyperplasia * Associated submucosal myoma * Person under guardianship * Patient with contraindication to general anesthesia or spinal anesthesia * Person in an exclusion period (determined by a previous or ongoing study) * Inability to give the eprosn informed information (comprehension difficulties ...)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Endometrial polyps are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital, Strasbourg, france
Strasbourg, 67000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.